Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Tharin Limsakun being referenced
Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Tharin Limsakun | 63 | 15 | 60 | 106 | 60 | 13 | 293 | |
| Sherri Smith | 22 | 27 | 47 | 183 | 17 | 17 | 323 | |
| Guohong Gao | 17 | 9 | 33 | 164 | 35 | 12 | 322 | |
| Harutake Sakura | 15 | 9 | 145 | 123 | 37 | 22 | 333 | |
| Meisheng Yu | 53 | 3 | 29 | 228 | 17 | 13 | 327 | |
| Elisa J. Cops | 30 | 1 | 71 | 103 | 19 | 12 | 301 | |
| Noortje van Gils | 86 | 60 | 85 | 165 | 34 | 14 | 300 | |
| Mark Ma | 53 | 3 | 79 | 154 | 22 | 18 | 305 | |
| Markus Lechner | 21 | 4 | 27 | 145 | 20 | 14 | 322 | |
| Adolfo Quiñones‐Lombraña | 10 | 18 | 48 | 104 | 44 | 19 | 294 | |
| Poorva Jain | 26 | 11 | 18 | 100 | 21 | 11 | 274 |
All Works
Loading papers...